Health & Bio Today: GSK's efimosfermin wins FDA Breakthrough and EMA PRIME status, PureTech Health, Ondine Biomedical, AstraZeneca tickstock newsroom · 17:06, 27 Apr 2026
Seaport Therapeutics appoints Intra‑Cellular founder Sharon Mates to board tickstock newsroom · 12:54, 27 Apr 2026
AOTI shares surge after study shows 64.8% complete healing tickstock newsroom · 08:06, 27 Apr 2026 · Updated 10:20, 27 Apr
One Health Group says revenue and EBITDA will be ahead of market expectations tickstock newsroom · 09:48, 27 Apr 2026
Ondine study shows 39.5% cut in ICU pneumonia and is accepted for CACCN oral presentation tickstock newsroom · 08:06, 27 Apr 2026
AstraZeneca wins US approval for once-weekly Saphnelo self-injection tickstock newsroom · 08:05, 27 Apr 2026
GSK subsidiary TESARO has anticipatory breach claim dismissed by Delaware court tickstock newsroom · 08:05, 27 Apr 2026
The Premarket Brief: ECR Minerals, Ondine Biomedical, 88 Energy, Pathos Communications, Beowulf Mining tickstock newsroom · 08:03, 27 Apr 2026
Shield Therapeutics partner MEDLEAP confirms first patient enrollment in Japan Phase II for ACCRUFeR tickstock newsroom · 07:27, 27 Apr 2026
Hikma reiterates full-year 2026 guidance after encouraging start to the year tickstock newsroom · 07:32, 23 Apr 2026 · Updated 13:44, 23 Apr
Ondine Biomedical (AIM:OBI) shares surged 7.4% after Ottawa Heart Institute study tickstock newsroom · 08:17, 23 Apr 2026
Foxtons Group (LSE:FOXT) shares fell 3.4% after Q1 trading in line tickstock newsroom · 07:32, 23 Apr 2026
PureTech posts positive Phase 1b LYT-200 data and will prioritise relapsed/refractory high‑risk MDS tickstock newsroom · 07:13, 23 Apr 2026
Ondine Biomedical to showcase at World Congress on Infectious Diseases tickstock newsroom · 12:33, 22 Apr 2026
Helical advances lettings and de‑risks pipeline ahead of full‑year results tickstock newsroom · 12:30, 22 Apr 2026
Renalytix expands testing capacity 3.5x and submits CE technical file for kidneyintelX.dkd tickstock newsroom · 12:26, 22 Apr 2026
hVIVO to run pivotal Phase III whooping cough human challenge trial for ILiAD tickstock newsroom · 07:26, 22 Apr 2026
Avacta demonstrates AVA6103 outdelivers Enhertu and reveals dual‑payload in vivo data tickstock newsroom · 07:33, 21 Apr 2026
CRISM Therapeutics shows 58% tumour reduction with Docetaxel-ChemoSeed tickstock newsroom · 07:30, 21 Apr 2026
IXICO reports 23% H1 revenue rise as order book expands to £18.1m tickstock newsroom · 07:27, 21 Apr 2026
genedrive in line for NHS-wide MT‑RNR1 tender as England publishes premarket engagement tickstock newsroom · 07:25, 21 Apr 2026
AstraZeneca's Ultomiris meets primary endpoint in IgAN Phase III tickstock newsroom · 07:24, 21 Apr 2026
Feedback secures QVH licence extension after NHS decision delayed tickstock newsroom · 09:43, 20 Apr 2026
The Premarket Brief: GSK wins China approval for Blenrep in myeloma, Renishaw, Mulberry, Plus500, Supreme, Nanoco, ATOME, Smarter Web Company, Angus Energy tickstock newsroom · 08:03, 20 Apr 2026
AstraZeneca reports tozorakimab cuts COPD exacerbations in Phase III MIRANDA tickstock newsroom · 07:26, 20 Apr 2026
CelLBxHealth partners with The Royal Marsden on 200‑patient CTC study tickstock newsroom · 07:26, 20 Apr 2026
Kooth gains validation for Soluna from California impact report tickstock newsroom · 07:17, 20 Apr 2026
Genflow Biosciences secures fully funded LNP collaboration with Acuitas Therapeutics tickstock newsroom · 07:17, 20 Apr 2026
Optima Health says full year earnings will be beat expectations tickstock newsroom · 08:55, 17 Apr 2026
Obsidian to go public via Galera reverse merger backed by $350m private placement tickstock newsroom · 11:06, 15 Apr 2026
Ondine-backed ICU pilot cuts pneumonia by 39.5% with five-minute nasal treatment tickstock newsroom · 22:05, 14 Apr 2026
Ondine boosted by patient enrolment, revenues rise and factory upgrades begin tickstock newsroom · 23:44, 13 Apr 2026
OXB launches fast-track services to cut GMP timelines by up to nine months tickstock newsroom · 23:39, 13 Apr 2026
MedPal launches Health OS to close the wearable-to-prescription loop in the UK tickstock newsroom · 15:38, 8 Apr 2026
Genflow says its gene therapy for dogs maintains safety and efficacy three months after dosing tickstock newsroom · 15:38, 8 Apr 2026
Kooth weathers 2025 revenue dip as Soluna embeds in California and adjusted EBITDA holds at £11.3m tickstock newsroom · 15:34, 8 Apr 2026
Market reports Daily reports The Premarket Brief London LIVE Small Caps Today Sector reports Mining Today Oil & Gas Today Health & Bio Today Tech Today
Energy & Resources Topics Oil & Gas Mining & Metals Renewables Nuclear Top Stocks AAL Anglo American ANTO Antofagasta FRES Fresnillo EDV Endeavour Mining GGP Greatland Gold See all companies
Financials Topics Banks Insurance Asset Management Fintech & Payments REITs & Property Top Stocks BARC Barclays HSBA HSBC LLOY Lloyds NWG NatWest AV. Aviva PRU Prudential See all companies
Technology Topics Software & SaaS Semiconductors AI & Machine Learning Cybersecurity Top Stocks SGE Sage Group RPI Raspberry Pi KNOS Kainos SCT Softcat See all companies
Healthcare Topics Pharma Biotech Medtech Healthcare Services Top Stocks AZN AstraZeneca GSK GSK SN. Smith & Nephew HIK Hikma See all companies
Industrials Topics Aerospace & Defence Construction Engineering Transport & Logistics Top Stocks BA. BAE Systems RR. Rolls-Royce BAB Babcock QQ. QinetiQ CHG Chemring See all companies
Consumer Topics Retail Food & Beverage Travel & Leisure Media & Entertainment Top Stocks DGE Diageo ULVR Unilever TSCO Tesco NXT Next See all companies
